Oura valuation, funding and investors
Oura works in wearable health device manufacturing, based in Oulu, Finland. Founded in 2013, it has about 1,620 employees.
VALUATION · TODAY
$15.73B +0% after Series E
Range $9.70B – $18.10B · Grade BTODAY
+12 MO
$5.00B
$10.00B
$15.00B
$20.00B
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $2.30M
Seed $2.25M
Series A $5.30M
Series B $28.0M
Series C $100M
Series D $200M
Series E $875M
Valuation12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY1,617 employees
+23%6m growth
+54%1y growth
+709%2y growth
1,000
2,000
Data from Jan 2021
Predicted in 1 yr $15.73B +0% vs today
Predicted next raise $1.89B if a round comes
Winding-down probability 0%
- Last round
- Series E · $875M · Sep 2025
- Valuation at last round
- $11.00B
- Headcount
- 1,617 · growing
- Grade
- B
- Founded
- 2013
Oura valuation today
VCMC values Oura at $15.7B today, with a range of $9.7B to $18.1B and a grade of B. The valuation starts from its last funding round, a Series E round in Sep 2025.
Valuation by date (173 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2013 | $8.44M | $5.55M – $25.7M | $16.9M (+100%) | after a round | – | unknown | C | 0% |
| 2 Jan 2013 | $8.46M | $5.55M – $25.7M | $16.9M (+100%) | after a round | – | unknown | C | 0% |
| 1 Feb 2013 | $8.95M | $5.55M – $25.7M | $16.9M (+89%) | after a round | – | unknown | C | 0% |
| 1 Mar 2013 | $9.44M | $5.55M – $25.7M | $16.9M (+79%) | after a round | – | unknown | C | 0% |
| 1 Apr 2013 | $10.0M | $5.55M – $25.7M | $16.9M (+69%) | after a round | – | unknown | C | 0% |
| 1 May 2013 | $10.6M | $5.55M – $25.7M | $16.9M (+59%) | after a round | – | unknown | C | 0% |
| 1 Jun 2013 | $11.2M | $5.55M – $25.7M | $16.9M (+50%) | after a round | – | unknown | C | 0% |
| 1 Jul 2013 | $11.9M | $5.55M – $25.7M | $16.9M (+42%) | after a round | – | unknown | C | 0% |
| 1 Aug 2013 | $12.6M | $5.55M – $25.7M | $16.9M (+34%) | after a round | – | unknown | C | 0% |
| 1 Sep 2013 | $13.4M | $5.55M – $25.7M | $16.9M (+26%) | after a round | – | unknown | C | 0% |
| 1 Oct 2013 | $14.2M | $5.55M – $25.7M | $16.9M (+19%) | after a round | – | unknown | C | 0% |
| 1 Nov 2013 | $15.0M | $5.55M – $25.7M | $16.9M (+12%) | after a round | – | unknown | C | 0% |
| 1 Dec 2013 | $15.9M | $5.55M – $25.7M | $16.9M (+6%) | after a round | – | unknown | C | 0% |
| 1 Jan 2014 | $16.9M | $5.55M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2014 | $16.9M | $5.27M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2014 | $16.9M | $5.04M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2014 | $16.9M | $4.79M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2014 | $16.9M | $4.56M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2014 | $16.9M | $4.33M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2014 | $16.9M | $4.12M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2014 | $16.9M | $3.92M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2014 | $16.9M | $3.72M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2014 | $16.9M | $3.54M – $25.7M | $16.9M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2014 | $16.9M | $3.37M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2014 | $16.9M | $3.21M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2015 | $16.9M | $3.05M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2015 | $16.9M | $2.89M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2015 | $16.9M | $2.76M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2015 | $16.9M | $2.63M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2015 | $16.9M | $2.50M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2015 | $16.9M | $2.38M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2015 | $16.9M | $2.26M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2015 | $16.9M | $2.15M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2015 | $16.9M | $2.04M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2015 | $16.9M | $1.95M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2015 | $16.9M | $1.85M – $25.7M | $16.9M (0%) | after a round | – | unknown | D | 0% |
| 12 Nov 2015 | $8.28M | $5.43M – $25.2M | $16.5M (+100%) | after a round | – | unknown | C | 0% |
| 1 Dec 2015 | $8.59M | $5.43M – $25.2M | $16.5M (+93%) | after a round | – | unknown | C | 0% |
| 1 Jan 2016 | $9.11M | $5.43M – $25.2M | $16.5M (+82%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $9.66M | $5.43M – $25.2M | $16.5M (+71%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $10.2M | $5.43M – $25.2M | $16.5M (+62%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $10.8M | $5.43M – $25.2M | $16.5M (+53%) | after a round | – | unknown | C | 0% |
| 1 May 2016 | $11.5M | $5.43M – $25.2M | $16.5M (+44%) | after a round | – | unknown | C | 0% |
| 1 Jun 2016 | $12.2M | $5.43M – $25.2M | $16.5M (+36%) | after a round | – | unknown | C | 0% |
| 1 Jul 2016 | $12.9M | $5.43M – $25.2M | $16.5M (+29%) | after a round | – | unknown | C | 0% |
| 1 Aug 2016 | $13.6M | $5.43M – $25.2M | $16.5M (+21%) | after a round | – | unknown | C | 0% |
| 1 Sep 2016 | $14.5M | $5.43M – $25.2M | $16.5M (+14%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $15.3M | $5.43M – $25.2M | $16.5M (+8%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $16.2M | $5.43M – $25.2M | $16.5M (+2%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $23.1M | $16.2M – $58.8M | $41.5M (+80%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $24.3M | $16.2M – $58.8M | $41.5M (+71%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $25.5M | $16.2M – $58.8M | $41.5M (+63%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $26.7M | $16.2M – $58.8M | $41.5M (+55%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $28.0M | $16.2M – $58.8M | $41.5M (+48%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $29.4M | $16.2M – $58.8M | $41.5M (+41%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $30.9M | $16.2M – $58.8M | $41.5M (+34%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $32.5M | $16.2M – $58.8M | $41.5M (+28%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $34.1M | $16.2M – $58.8M | $41.5M (+22%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $35.9M | $16.2M – $58.8M | $41.5M (+16%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $37.6M | $16.2M – $58.8M | $41.5M (+10%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $39.6M | $16.2M – $58.8M | $41.5M (+5%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $41.5M | $16.2M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $41.5M | $15.4M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $41.5M | $14.6M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $41.5M | $14.0M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $41.5M | $13.3M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $41.5M | $12.7M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $41.5M | $12.0M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $41.5M | $11.4M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $41.5M | $10.9M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $41.5M | $10.3M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $41.5M | $9.84M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $41.5M | $9.35M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $41.5M | $8.90M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $41.5M | $8.46M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $41.5M | $8.04M – $58.8M | $41.5M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $41.5M | $7.68M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2019 | $41.5M | $7.30M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2019 | $41.5M | $6.95M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2019 | $41.5M | $6.60M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2019 | $41.5M | $6.28M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2019 | $41.5M | $5.97M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2019 | $41.5M | $5.68M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2019 | $41.5M | $5.40M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2019 | $41.5M | $5.13M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2019 | $41.5M | $4.89M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2020 | $41.5M | $4.65M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2020 | $41.5M | $4.41M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2020 | $41.5M | $4.21M – $58.8M | $41.5M (0%) | after a round | – | unknown | D | 0% |
| 18 Mar 2020 | $184M | $121M – $419M | $275M (+50%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $187M | $121M – $419M | $275M (+48%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $193M | $121M – $419M | $275M (+43%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $200M | $121M – $419M | $275M (+38%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $206M | $121M – $419M | $275M (+33%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $214M | $121M – $419M | $275M (+29%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $221M | $121M – $419M | $275M (+24%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $229M | $121M – $419M | $275M (+20%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $237M | $121M – $419M | $275M (+16%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $245M | $121M – $419M | $275M (+13%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $253M | $121M – $419M | $275M (+9%) | after a round | 200 | unknown | C | 0% |
| 1 Feb 2021 | $262M | $121M – $419M | $275M (+5%) | after a round | 200 | unknown | C | 0% |
| 1 Mar 2021 | $270M | $121M – $419M | $275M (+2%) | after a round | 200 | unknown | C | 0% |
| 1 Apr 2021 | $275M | $118M – $419M | $275M (0%) | after a round | 200 | flat | C | 0% |
| 1 May 2021 | $275M | $113M – $419M | $275M (0%) | after a round | 200 | flat | C | 0% |
| 5 May 2021 | $591M | $416M – $1.1B | $768M (+30%) | after a round | 200 | flat | B | 0% |
| 1 Jun 2021 | $602M | $416M – $1.1B | $768M (+27%) | after a round | 200 | flat | B | 0% |
| 1 Jul 2021 | $616M | $416M – $1.1B | $768M (+25%) | after a round | 200 | flat | B | 0% |
| 1 Aug 2021 | $629M | $416M – $1.1B | $768M (+22%) | after a round | 200 | flat | B | 0% |
| 1 Sep 2021 | $644M | $416M – $1.1B | $768M (+19%) | after a round | 200 | flat | B | 0% |
| 1 Oct 2021 | $658M | $416M – $1.1B | $768M (+17%) | after a round | 200 | flat | B | 0% |
| 1 Nov 2021 | $672M | $416M – $1.1B | $768M (+14%) | after a round | 200 | flat | B | 0% |
| 1 Dec 2021 | $687M | $416M – $1.1B | $768M (+12%) | after a round | 200 | flat | B | 0% |
| 1 Jan 2022 | $703M | $416M – $1.1B | $768M (+9%) | after a round | 200 | flat | B | 0% |
| 1 Feb 2022 | $718M | $416M – $1.1B | $768M (+7%) | after a round | 200 | flat | B | 0% |
| 1 Mar 2022 | $733M | $416M – $1.1B | $768M (+5%) | after a round | 200 | flat | B | 0% |
| 1 Apr 2022 | $749M | $416M – $1.1B | $768M (+2%) | after a round | 200 | flat | B | 0% |
| 1 May 2022 | $766M | $416M – $1.1B | $768M (0%) | after a round | 200 | flat | B | 0% |
| 1 Jun 2022 | $768M | $399M – $1.1B | $768M (0%) | after a round | 200 | flat | B | 0% |
| 1 Jul 2022 | $768M | $382M – $1.1B | $768M (0%) | after a round | 200 | flat | B | 0% |
| 1 Aug 2022 | $768M | $364M – $1.1B | $768M (0%) | after a round | 200 | unknown | B | 0% |
| 1 Sep 2022 | $768M | $348M – $1.1B | $768M (0%) | after a round | 200 | unknown | B | 0% |
| 1 Oct 2022 | $768M | $333M – $1.1B | $768M (0%) | after a round | 200 | unknown | B | 0% |
| 1 Nov 2022 | $768M | $317M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Dec 2022 | $768M | $304M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Jan 2023 | $768M | $290M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Feb 2023 | $768M | $277M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Mar 2023 | $768M | $265M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Apr 2023 | $768M | $253M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 May 2023 | $768M | $242M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Jun 2023 | $768M | $218M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Jul 2023 | $768M | $208M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Aug 2023 | $768M | $197M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Sep 2023 | $768M | $188M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Oct 2023 | $768M | $179M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Nov 2023 | $768M | $170M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Dec 2023 | $768M | $162M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Jan 2024 | $768M | $154M – $1.1B | $768M (0%) | after a round | 200 | unknown | C | 0% |
| 1 Feb 2024 | $768M | $146M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Mar 2024 | $768M | $139M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Apr 2024 | $768M | $132M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 May 2024 | $768M | $126M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Jun 2024 | $768M | $120M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Jul 2024 | $768M | $114M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Aug 2024 | $768M | $108M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Sep 2024 | $768M | $103M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Oct 2024 | $768M | $97.9M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Nov 2024 | $768M | $93.0M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 1 Dec 2024 | $768M | $88.6M – $1.1B | $768M (0%) | after a round | 200 | unknown | D | 0% |
| 20 Dec 2024 | $5.2B | $4.5B – $7.8B | $6.8B (+30%) | after a round | 200 | unknown | A | 0% |
| 1 Jan 2025 | $5.2B | $4.5B – $7.8B | $6.8B (+29%) | after a round | 200 | unknown | A | 0% |
| 1 Feb 2025 | $5.4B | $4.5B – $7.8B | $6.8B (+26%) | after a round | 200 | unknown | A | 0% |
| 1 Mar 2025 | $5.5B | $4.5B – $7.8B | $6.8B (+23%) | after a round | 200 | unknown | A | 0% |
| 1 Apr 2025 | $5.6B | $4.5B – $7.8B | $6.8B (+21%) | after a round | 200 | unknown | A | 0% |
| 1 May 2025 | $5.7B | $4.5B – $7.8B | $6.8B (+18%) | after a round | 200 | unknown | A | 0% |
| 1 Jun 2025 | $5.9B | $4.5B – $7.8B | $6.8B (+16%) | after a round | 200 | unknown | A | 0% |
| 1 Jul 2025 | $6.0B | $4.5B – $7.8B | $6.8B (+13%) | after a round | 936 | unknown | A | 0% |
| 1 Aug 2025 | $6.1B | $4.5B – $7.8B | $6.8B (+11%) | after a round | 936 | unknown | A | 0% |
| 1 Sep 2025 | $6.2B | $4.5B – $7.8B | $6.8B (+8%) | after a round | 936 | unknown | A | 0% |
| 23 Sep 2025 | $11.0B | $9.6B – $16.4B | $14.3B (+30%) | after a round | 936 | unknown | A | 0% |
| 1 Oct 2025 | $11.1B | $9.6B – $16.4B | $14.3B (+29%) | after a round | 1,048 | up | A | 0% |
| 1 Nov 2025 | $11.3B | $9.6B – $16.4B | $14.3B (+26%) | after a round | 1,048 | up | A | 0% |
| 1 Dec 2025 | $11.6B | $9.6B – $16.4B | $14.3B (+24%) | after a round | 1,048 | up | A | 0% |
| 1 Jan 2026 | $11.8B | $9.6B – $16.4B | $14.3B (+21%) | after a round | 1,048 | up | A | 0% |
| 1 Feb 2026 | $12.1B | $9.6B – $16.4B | $14.3B (+18%) | after a round | 1,048 | up | A | 0% |
| 1 Mar 2026 | $12.3B | $9.6B – $16.4B | $14.3B (+16%) | after a round | 1,048 | up | A | 0% |
| 1 Apr 2026 | $13.0B | $9.6B – $17.3B | $15.0B (+16%) | after a round | 1,317 | growing | A | 0% |
| 1 May 2026 | $13.4B | $9.6B – $17.4B | $15.2B (+14%) | after a round | 1,370 | growing | B | 0% |
| 1 Jun 2026 | $13.7B | $9.6B – $17.4B | $15.2B (+10%) | after a round | 1,370 | growing | B | 0% |
| 1 Jul 2026 | $14.1B | $9.6B – $17.4B | $15.2B (+8%) | after a round | 1,370 | growing | B | 0% |
| 1 Aug 2026 | $14.7B | $9.6B – $17.8B | $15.4B (+5%) | after a round | 1,489 | growing | B | 0% |
| 1 Sep 2026 | $15.1B | $9.6B – $17.8B | $15.4B (+2%) | after a round | 1,489 | growing | B | 0% |
| 1 Oct 2026 | $15.7B | $9.6B – $18.1B | $15.7B (0%) | after a round | 1,617 | growing | B | 0% |
| 24 Oct 2026 | $15.7B | $9.7B – $18.1B | $15.7B (0%) | after a round | 1,617 | growing | B | 0% |
Key facts about Oura
- Founded
- 2013
- Headquarters
- Oulu, Finland
- Employees
- about 1,620 +54% in a year
- Total raised
- $1.46B
- Funding rounds
- 8
- Last round
- Series E Sep 2025
Oura was founded in 2013 by Kari Kivelä, Markku Koskela and Petteri Lahtela.
Oura funding history
Oura has 8 funding rounds on record, from Jan 2013 to Sep 2025, $1.46B in total. The latest disclosed valuation is $11.00B post-money (Series E, Sep 2025).
Series E 22 Sep 2025
Investors not disclosed.
Sources: techfundingnews.com, longevityinvestorsnews.ch, allhealthtech.com and 1 more
$875M
$11.00B post-money
Debt 22 Sep 2025no round page
With JPMorgan Chase, Goldman Sachs, Barclays.
Sources: techfundingnews.com
$250M
Series D 19 Dec 2024
Led by Fidelity Management & Research Company, Dexcom; with Fidelity Management.
Sources: finsmes.com, mobihealthnews.com, drugdeliverybusiness.com and 3 more
$200M
$5.20B post-money
Series C 4 May 2021
Led by The Chernin Group, Elysian Park; with Temasek, JAZZ Venture Partners, Eisai Innovation, Bedford Ridge, One Capital, Forerunner, Square, MSD Capital, Lifeline Ventures, Metaplanet, Next Ventures, Marc Benioff.
Sources: finsmes.com, mobihealthnews.com, techcrunch.com and 1 more
$100M
Series B 17 Mar 2020
With Forerunner, Gradient, Square.
Sources: finsmes.com, techcrunch.com, mobihealthnews.com and 2 more
$28M
Series A 30 Nov 2016
Investors not disclosed. Individuals: Jaan Tallinn, Joi Ito.
Sources: prnewswire.com, techcrunch.com
$5.3M
Seed 11 Nov 2015
Led by Lifeline Ventures; with Proxy Ventures.
Sources: theguycornernyc.com, en.wikipedia.org
$2.3M
$2.3M
Oura investors
22 investors have backed Oura; Lifeline Ventures, Dexcom and Elysian Park and 2 more led at least one round.
- Dexcom lead
- Elysian Park lead
- Fidelity Management & Research Company lead
- Square 2 rounds
- Barclays
- Bedford Ridge
- Fidelity Management
- Goldman Sachs
- JPMorgan Chase
- Marc Benioff
- MSD Capital
- One Capital
- Proxy Ventures
- Temasek
What Oura does
Oura works in medical supply manufacturers, with 12 recorded offerings and customers in healthcare and consumer electronics.
Oura Health Oy is a Finnish company engaged in the development and distribution of wearable health technology devices, with a focus on sleep monitoring, fitness tracking, and stress measurement. The company also operates as a software developer and provides a platform for data sharing with healthcare providers, researchers, and employers. Oura serves a global market and offers its products in multiple languages and operating systems.
Description from Veridion's company data.
Products and services
- Wearable Health Device Manufacturing
- Wearable Health Device Distribution
- Wearable Health Data Analytics
- Health Data Platform Development
- Health Data Sharing Services
- Personalized Health Insights Services
- Wearable Technology Software Development
- Health Technology Product Innovation
- Health Technology Product Distribution
- Flexible Health Device Financing Solutions
- Multi-Language Health Device Distribution
- Multi-Platform Health Device Compatibility Services
Markets
- Healthcare
- Consumer Electronics
Business model
- Business-to-Business
- Business-to-Consumer
- Manufacturing
- Retail
Industry codes (NAICS)
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing 50% match
- 449210 Electronics and Appliance Retailers 30% match
- 541511 Custom Computer Programming Services 20% match
Questions about Oura
What is Oura worth?
Valuation $15.7B (range $9.7B to $18.1B), as of 24 Oct 2026. The last disclosed valuation was $11.00B (Series E, Sep 2025).
Has Oura raised money?
Oura has 8 funding rounds on record, from Jan 2013 to Sep 2025, $1.46B in total. The latest disclosed valuation is $11.00B post-money (Series E, Sep 2025).
Who has invested in Oura?
Lifeline Ventures, Dexcom, Elysian Park, Fidelity Management & Research Company, The Chernin Group and Forerunner, and 16 more. Lead investors include Lifeline Ventures, Dexcom, Elysian Park and Fidelity Management & Research Company.
How many people work at Oura?
About 1,620, up 54% over the last year. Headcount grew from 200 in Jan 2021 to 1,617 in Sep 2026.
What does Oura do?
Oura works in medical supply manufacturers, with 12 recorded offerings and customers in healthcare and consumer electronics. Its main offerings are wearable health device manufacturing, wearable health device distribution and wearable health data analytics.
When was Oura founded, and where is it based?
Oura was founded in 2013 and is based in Oulu, Finland. It has about 1,620 employees, up 54% over the last year.